Ozempic Pill Flops in Major Trials for Alzheimer’s

2025-11-24 | original

read original get Medication → more articles

An oral version of the GLP-1 drug semaglutide failed to significantly slow the disease's progression compared to a placebo.

Explore topics: compared compared placebo disease disease progression drug